Oscar Health Stock Drops 1.26% Bucking Broader Market Gains

OSCR Declines 8.85% in One Month, Lagging Market

Oscar Health, Inc. (OSCR) shares declined 1.26% to close at $14.84 on December 23, diverging from a positive session for the broader market. The S&P 500 recorded a 0.46% gain, while the Dow Jones Industrial Average rose 0.17%. This underperformance extends over a longer period, with OSCR shares falling 8.85% over the last month. During the same timeframe, the S&P 500 gained 4.22% and the Finance sector, to which Oscar belongs, added 5.73%.

Revenue Growth Projected at 34% as Profitability Wavers

Investors are closely watching the company's upcoming financial results, which present a mixed outlook. The consensus estimate for revenue is $3.21 billion, a significant 33.98% increase compared to the prior-year quarter. However, this top-line growth is overshadowed by profitability concerns, with earnings per share (EPS) expected to come in at -$0.84, representing a 35.48% deterioration from the same period last year. Full-year estimates mirror this trend, with analysts expecting revenue to reach $12.1 billion, up 31.86%, while full-year EPS is projected at -$1.35. Despite the negative earnings forecast, the Zacks Consensus EPS estimate has risen 2.88% over the past month, and the stock currently holds a Zacks Rank of #3 (Hold).